Location History:
- St. Louis, MO (US) (2001)
- St. Louis, MI (US) (2001)
Company Filing History:
1 out of 1 
1 out of 832,812 Years Active: 2001
Title: **Innovative Contributions of Ramaiah Nagaraja in Biomedicine**
Introduction
Ramaiah Nagaraja is a notable inventor based in St. Louis, MO, recognized for his significant contributions to the field of biomedicine. With a total of two patents under his name, he has focused his research on advancements that are pivotal for diagnosing and treating fragile X syndrome, a genetic condition linked to mental retardation.
Latest Patents
Nagaraja's latest patents include advancements in monoclonal and polyclonal antibodies relating to fragile X syndrome. He has successfully obtained and purified the DNA sequence spanning the fragile X site on the X human chromosome. This breakthrough is crucial as it provides a means for diagnosis and potential treatment of related mental disorders. The patents disclose specific antibodies targeting an amino acid sequence encoded by SEQ ID NO:1, which enhances understanding and management of fragile X syndrome.
Career Highlights
Throughout his career, Nagaraja has worked in various esteemed institutions, including the Adelaide Medical Centre for Women and Children. His expertise in biomedicine has led to significant breakthroughs in genetic research and therapy, establishing him as a respected figure in his field.
Collaborations
Nagaraja has collaborated with esteemed professionals, including Grant R. Sutherland and Robert I. Richards. Their collective efforts have contributed greatly to advancements in genetic research and the development of therapeutic approaches for complex medical conditions.
Conclusion
Ramaiah Nagaraja stands out as an influential inventor whose work has direct implications for the diagnosis and treatment of fragile X syndrome. His innovative patents and collaborations with other experts in the field highlight the importance of continued research and development in biomedicine. As the understanding of genetic conditions progresses, Nagaraja's contributions are sure to play a vital role in improving patient outcomes.